Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols, and Berberine) in Patients with Low-Moderate Risk Hypercholesterolemia: A Double-Blind, Placebo-Controlled Study
Background: Statins are at the forefront of strategies to manage hypercholesterolemia. However 10% to 15% of patients are intolerant to any statin drugs, even at low daily doses and almost one-third of statin users discontinue therapy within 1 year. Some nutraceuticals are prescribed as lipid-loweri...
Saved in:
Main Authors: | Stefano Gonnelli, MD (Author), Carla Caffarelli, MD, PhD (Author), Kostantinos Stolakis, MD (Author), Claudia Cuda (Author), Nicola Giordano, MD (Author), Ranuccio Nuti, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2015-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Lipid-Lowering Efficacy of a Nutraceutical Combination Including Leucoselect Phytosome, Red Yeast Rice, Policosanol and Folic Acid in Dyslipidaemia Patients: Real-World Insights
by: Vincenzo Russo, et al.
Published: (2024) -
Efficacy Assessment of Five Policosanol Brands and Damage to Vital Organs in Hyperlipidemic Zebrafish by Six-Week Supplementation: Highlighting the Toxicity of Red Yeast Rice and Safety of Cuban Policosanol (Raydel<sup>®</sup>)
by: Kyung-Hyun Cho, et al.
Published: (2024) -
Lipid Profile and Vascular Remodelling in Young Dyslipidemic Subjects Treated with Nutraceuticals Derived from Red Yeast Rice
by: Massimo Puato, et al.
Published: (2021) -
Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with bone disease severity in Rett syndrome
by: Carla Caffarelli, et al.
Published: (2020) -
Diet and Lipid-Lowering Nutraceuticals in Pediatric Patients with Familial Hypercholesterolemia
by: Maria Elena Capra, et al.
Published: (2024)